{"id":"W3029351535","doi":"10.1038/s41586-020-2267-z","title":"Evaluating drug targets through human loss-of-function genetic variation","year":2020,"lang":"en","type":"article","venue":"Nature","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":181,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute; University of Ottawa","funders":"Common Fund; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Mental Health; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institutes of Health; Broad Institute; Rosetrees Trust; Imperial College London; National Institute of General Medical Sciences; National Institute for Health and Care Research; National Institute of Allergy and Infectious Diseases; Medical Research Council; Barts Charity; National Human Genome Research Institute; Wellcome Trust; National Cancer Institute; British Heart Foundation","keywords":"Human genetic variation; Genetic variation; Gene; Drug; Drug development; Human genetics; Drug discovery; Human genome; Drug target","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005281943,0.00008441821,0.00007875155,0.000009149374,0.00006378323,0.000009963751,0.00009918569,0.0003262121,0.00003253065],"category_scores_gemma":[0.00007889795,0.00007923339,0.00006772247,0.0000584316,0.00001753213,0.000002576904,0.00004964268,0.0002200983,0.000004614339],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005091643,"about_ca_system_score_gemma":0.00004210428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007292814,"about_ca_topic_score_gemma":0.000003018026,"domain_scores_codex":[0.9994055,0.00003251858,0.0001273494,0.0002232974,0.0001165702,0.00009474044],"domain_scores_gemma":[0.9996338,0.000003913584,0.00008324247,0.0001366752,0.0001019361,0.00004036661],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00007320839,0.00003701809,0.001686813,0.00004626108,0.00005513278,0.000002817951,0.0002485683,0.0007949818,0.9916583,0.0003551106,0.004305336,0.0007364196],"study_design_scores_gemma":[0.004595965,0.002604732,0.3632767,0.00007267618,0.0005696644,0.00002607436,0.0004226269,0.002748326,0.5114382,0.01437981,0.09843331,0.001431934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936535,0.004161737,0.0009966496,0.0003842583,0.0001794348,0.0001232221,0.00002527399,0.000009499447,0.0004664366],"genre_scores_gemma":[0.996162,0.00004485335,0.001824252,0.001250772,0.0004212995,0.000004868992,0.0002193876,0.00001353428,0.00005900604],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4802201,"threshold_uncertainty_score":0.3231044,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01617241263979258,"score_gpt":0.302223902009173,"score_spread":0.2860514893693804,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}